Relative risk of more than 1 fracture: hyperparathyroid subjects versus controls
| . | Crude (95% CI) . | Adjusted (95% CI)a . |
|---|---|---|
| Overall fractures | ||
| Control group | 1 | 1 |
| Normocalcemic | 1.13 (0.57-2.29) | 1,12 (0.56-2,27) |
| Hypercalcemic | 2.37 (1.30-4.56) | 2.24 (1.22-4.32) |
| Moderate-severe fractures | ||
| Control group | 1 | 1 |
| Normocalcemic | 0.83 (0.23-2.98) | 0.83 (0.23-2.97) |
| Hypercalcemic | 2.73 (1.04-8.45) | 2.60 (0.99-8.08) |
| . | Crude (95% CI) . | Adjusted (95% CI)a . |
|---|---|---|
| Overall fractures | ||
| Control group | 1 | 1 |
| Normocalcemic | 1.13 (0.57-2.29) | 1,12 (0.56-2,27) |
| Hypercalcemic | 2.37 (1.30-4.56) | 2.24 (1.22-4.32) |
| Moderate-severe fractures | ||
| Control group | 1 | 1 |
| Normocalcemic | 0.83 (0.23-2.98) | 0.83 (0.23-2.97) |
| Hypercalcemic | 2.73 (1.04-8.45) | 2.60 (0.99-8.08) |
aModels adjusted for age.
Relative risk of more than 1 fracture: hyperparathyroid subjects versus controls
| . | Crude (95% CI) . | Adjusted (95% CI)a . |
|---|---|---|
| Overall fractures | ||
| Control group | 1 | 1 |
| Normocalcemic | 1.13 (0.57-2.29) | 1,12 (0.56-2,27) |
| Hypercalcemic | 2.37 (1.30-4.56) | 2.24 (1.22-4.32) |
| Moderate-severe fractures | ||
| Control group | 1 | 1 |
| Normocalcemic | 0.83 (0.23-2.98) | 0.83 (0.23-2.97) |
| Hypercalcemic | 2.73 (1.04-8.45) | 2.60 (0.99-8.08) |
| . | Crude (95% CI) . | Adjusted (95% CI)a . |
|---|---|---|
| Overall fractures | ||
| Control group | 1 | 1 |
| Normocalcemic | 1.13 (0.57-2.29) | 1,12 (0.56-2,27) |
| Hypercalcemic | 2.37 (1.30-4.56) | 2.24 (1.22-4.32) |
| Moderate-severe fractures | ||
| Control group | 1 | 1 |
| Normocalcemic | 0.83 (0.23-2.98) | 0.83 (0.23-2.97) |
| Hypercalcemic | 2.73 (1.04-8.45) | 2.60 (0.99-8.08) |
aModels adjusted for age.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
